Affordable Health Care for Every American
Peter strongly believes that every American has a right to affordable health care. He is fighting to cut the skyrocketing cost of prescription drugs and advance cost-effective telemedicine technology.
- Pass Medicare for All
- Allow the importation of safe prescription drugs from Canada
- Cut the cost of prescription drugs for seniors by using Medicare’s purchasing power to demand a better deal from drug companies
- Remove barriers to the development of low cost generic drugs
- Block any attempt to overturn Roe v. Wade and repeal the Hyde Amendment
- Fully fund Planned Parenthood and Title X family planning services
- Provide significant resources to communities on the front lines of opioid epidemic
- Increase funding for NIH disease and drug research
More on Affordable Health Care for Every American
Washington – Rep. Mike Thompson (CA-05), Co-Chair of the Congressional Telehealth Caucus, along with fellow Co-Chairs Rep. Peter Welch (VT-AL), Rep. Bill Johnson (OH-06) and Rep David Schweikert (AZ-06), announced the introduction of the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act. This bipartisan and bicameral package will help expand access to important telehealth services that can lower health costs and make health care more efficient for patients.
WASHINGTON – Last night, the House Energy and Commerce Committee approved a major drug pricing reform bill that includes a price negotiation initiative long championed by Rep. Peter Welch.
The Lower Drug Costs Now Act of 2019 (H.R. 3) was approved by the House Energy and Commerce Committee by a vote of 30-22. The Congressional Budget Office estimates the bill will save at least $345 billion. It is expected to be considered by the full House in the near future.
WASHINGTON, DC – Today, Representatives Mary Gay Scanlon (PA-5), Brendan F. Boyle (PA-2), and Peter Welch (VT-At Large) introduced the Better Tools to Lower Costs Act of 2019 which would expand access to affordable prescription drugs for low-income Medicare beneficiaries by suspending a restrictive asset limit that prevents many in need from qualifying for relief.
WASHINGTON – Rep. Peter Welch (D-Vt.) today introduced bipartisan legislation with Rep. David McKinley (R-W.Va.) that would address a loophole contributing to the rising cost of health care for consumers and threatening access to lifesaving medications. The introduction of this legislation is the latest in Welch’s efforts to fix the broken prescription drug market that has led to unrestrained price increases for consumers and providers.
Washington, D.C. – The Ways & Means Committee approved the Seniors’ Chronic Care Management Improvement Act (H.R. 3436), introduced by Reps. Suzan DelBene (D-WA) and Peter Welch (D-VT). The bill eliminates coinsurance requirements for chronic care management (CCM) services which are non-patient facing, non-clinical services that providers perform behind the scenes to better coordinate care for Medicare beneficiaries with two or more chronic conditions.
WASHINGTON, D.C. – Oregon’s U.S. Sen. Jeff Merkley was joined by Congressmen Peter Welch (D-VT-AL) and Francis Rooney (R-FL-19) today in introducing bipartisan, bicameral legislation that would ensure Americans do not pay more for prescription drugs than people do in other developed countries—helping to address a top concern among Americans, who time and time again are facing the impossible choice between affording their prescriptions and paying their rent or putting food on the table.
WASHINGTON – This evening, by a vote of 234-183, the House of Representatives approved a multi-pronged health care package (H.R. 987) that will lower prescription drug prices and increase access to health care coverage through the Affordable Care Act (ACA).
The final bill includes five provisions written or co-sponsored by Rep. Peter Welch (D-Vt.). Video of Welch speaking on the bill can be found HERE.
WASHINGTON – Representative Peter Welch (D-Vt.) joined a bipartisan group of House and Senate members yesterday in introducing legislation to stop brand name drug company abuse of the drug approval process in order to block or slow more affordable generic drugs from coming to market.
The Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act would curb the common brand company practice of filing sham “citizen petitions” during the drug approval process that masquerade as public comments.
RUTLAND, Vt. – At a press conference this afternoon at Rutland Pharmacy, Rep. Peter Welch (D-Vt.) unveiled two bills that will protect Vermont’s local independent pharmacies that are at risk due to anti-competitive practices by middlemen in the prescription drug market. There are 41 independent pharmacies in Vermont employing 381 full time employees.
WASHINGTON, D.C. – Late yesterday, the House passed legislation introduced by Rep. Peter Welch (D-Vt.) that closes a loophole in the Medicaid program benefitting drug companies. The loophole allows the companies to minimize drug discounts they are required to provide to state and federal Medicaid programs.